Alzinova AB (publ) (STO:ALZ)
Sweden · Delayed Price · Currency is SEK 0.4575
+0.0160 (3.62%)
Jun 11, 2026, 5:29 PM CET
Alzinova AB Market Cap
Alzinova AB has a market cap or net worth of 70.89 million as of June 11, 2026. Its market cap has decreased by -62.20% in one year.
Market Cap
70.89M
Enterprise Value
60.31M
Revenue
25.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
Market Cap Chart
Since November 25, 2015, Alzinova AB's market cap has increased from 57.35M to 70.89M, an increase of 23.62%. That is a compound annual growth rate of 2.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 70.89M | -18.03% |
| Dec 30, 2025 | 86.48M | -71.97% |
| Dec 30, 2024 | 308.51M | 128.27% |
| Dec 29, 2023 | 135.15M | 50.50% |
| Dec 30, 2022 | 89.80M | -11.61% |
| Dec 30, 2021 | 101.60M | -13.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 105.67M |
| IRLAB Therapeutics AB | 105.15M |
| OncoZenge AB | 99.60M |
| AcouSort AB | 95.87M |
| Scandinavian ChemoTech AB | 92.14M |
| Annexin Pharmaceuticals AB | 91.77M |
| Spago Nanomedical AB | 72.77M |
| Pila Pharma AB | 68.52M |